Abstract
Drug development for complex diseases is shifting from targeting individual proteins or genes to systems-based attacks targeting dynamic network states. Lee et al. now reveal how the progressive rewiring of a signaling network over time following EGF receptor inhibition leaves triple-negative breast tumors vulnerable to a second, later hit with DNA-damaging drugs, demonstrating that time- and order-dependent drug combinations can be more efficacious in killing cancer cells.
Original language | English |
---|---|
Journal | Cell |
Volume | 149 |
Issue number | 4 |
Pages (from-to) | 731-733 |
ISSN | 0092-8674 |
DOIs | |
Publication status | Published - 2012 |